Establishment of 293 cell line inducibly expressing human IFITM3 and its inhibition to viral entry of H1N1 influenza virus

doi:10.3877/cma.j.issn.1674-1358.2018.02.020

Abstract

Abstract:

Objective

To establish FLP-IN T Rex 293 cell line inducibly expressing human interferon-inducible transmembrane protein 3 (IFITM3) and provide a cell model to explore the mechanism of IFITM3 inhibiting vial entry of influenza virus.

Methods

Full-length IFITM3 cDNA was cloned into pcDNA5/FRT/TO expression vector. Then 293 cell line inducibly expressing human IFITM3 was established by co-transfection of IFITM3/pcDNA5/FRT/TO expression vector and pOG44 plasmid and following antibiotic screening. The inducible expression of IFITM3 in 293 cells was tested by Western blot and immunofluorescence. The inhibitory effect of viral entry by IFITM3 was examined with H1N1 influenza virus pesudotyped virus (H1N1pp).

Results

The established FLP-IN T Rex 293 cell line of IFITM3 was able to express the target protein well, and the induced IFITM3 protein decreased the infection rate of H1N1 influenza pseudovirus by 97% (t = 38.08, P < 0.001), and the infection rate of vesicular stomatitis pseudovirus (VSVpp) decreased by 68% (t = 54.56, P < 0.001). Negative control group mice leukemia pseudovirus (MLVpp) infection rate (t = 1.282, P = 0.2208) and Lashapseudovirus (LASVpp) infection rate (t = 0.4814, P = 0.6377) had no significant influence.

Conclusions

FLP-IN T Rex 293 cell line inducibly expressing human IFITM3 is a pivotal restriction factor inhibiting H1N1 influenza virus entry. This IFITM3-inducible expression cell line can provide a useful platform to study IFITM3 antiviral mechanism.

Key words: Interferon-induced transmembrane protein 3, H1N1 influenza virus, Pseudoviruses, Inducible expression, Restriction factor

Zhifei Hou, Dong Jiang, Xuesen Zhao, Hui Zeng. Establishment of 293 cell line inducibly expressing human IFITM3 and its inhibition to viral entry of H1N1 influenza virus[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2018, 12(02): 198-203.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsyhlcgrbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1358.2018.02.020

https://zhsyhlcgrbzz.cma-cmc.com.cn/EN/Y2018/V12/I02/198

Figures/Tables 3

References 26

[1]	Paules C and Subbarao K. Influenza[J]. Lancet,2017,390(10095):697-708
[2]	Moghadami M. A narrative review of influenza: A seasonal and pandemic disease[J]. Iran J Med Sci,2017,42(1):2-13.
[3]	Bailey CC, Zhong G, Huang I, et al. Ifitm-family proteins: The cell’s first line of antiviral defense[J]. Annu Rev Virol,2014,1(1):261-283.
[4]	Huang IC, Bailey CC, Weyer JL, et al. Distinct patterns of ifitm-mediated restriction of filoviruses, sars coronavirus, and influenza a virus[J]. PLoS Pathog,2011,7(1):e1001258.
[5]	于媛媛, 时国朝. 干扰素诱导跨膜蛋白抗甲型流感病毒感染的作用及其机制[J]. 中华结核和呼吸杂志,2017,40(4):294-297.
[6]	陈永坤, 朱闻斐, 舒跃龙. 干扰素诱导的跨膜蛋白抗病毒作用的研究进展[J]. 病毒学报,2016,32(2):222-228.
[7]	Compton AA, Roy N, Porrot F, et al. Natural mutations in ifitm3 modulate post-translational regulation and toggle antiviral specificity[J]. Embo Rep,2016,17(11):1657-1671.
[8]	Fu B, Wang L, Li S, et al. Zmpste24 defends against influenza and other pathogenic viruses[J]. J Exp Med,2017,214(4):919.
[9]	Gerlach T, Hensen L, Matrosovich T, et al. Ph-optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza a viruses to the interferon-induced antiviral state and ifitms[J]. J Virol,2017,91(11):e00246-17.
[10]	Wang HF, Chen L, Luo J, et al. KLF5 is involved in regulation of ifitm1, 2, and 3 genes during h5n1 virus infection in a549 cells[J]. Cell Mol Biol,2016,62(13):65-70.
[11]	Florian W, Michael W, Stefan P. Ifitm proteins inhibit entry driven by the mers-coronavirus spike protein: evidence for cholesterol-independent mechanisms[J]. Viruses,2014,6(9):3683-3698.
[12]	Huang IC, Benita Y, John SP, et al. The ifitm proteins mediate cellular resistance to influenza a h1n1 virus, west nile virus, and dengue virus[J]. Cell,2009,139(7):1243-1254.
[13]	John SP, Chin CR, Perreira JM, et al. The cd225 domain of ifitm3 is required for both ifitm protein association and inhibition of influenza a virus and dengue virus replication[J]. J Virol,2013,87(14):7837-7852.
[14]	Huang IC, Bailey CC, Weyer JL, et al. Distinct patterns of ifitm-mediated restriction of filoviruses, sars coronavirus, and influenza a virus[J]. PLoS Pathog,2011,7(1):e1001258.
[15]	Jiang D, Weidner JM, Qing M, et al. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections[J]. J Virol,2010,84(16):8332.
[16]	Perreira JM, Chin CR, Feeley EM, et al. Ifitms restrict the replication of multiple pathogenic viruses[J]. J Mol Biol,2013,425(24):4937-4955.
[17]	Wrensch F, Karsten CB, Gnirß K, et al. Interferon-induced transmembrane protein-mediated inhibition of host cell entry of ebolaviruses[J]. J Infect Dis,2015,212(Suppl 2):S210.
[18]	Bailey CC, Zhong G, Huang I, et al. Ifitm-family proteins: The cell’s first line of antiviral defense[J]. Annu Rev Virol,2014,1(1):261-283.
[19]	Li K, Markosyan RM, Zheng YM, et al. Ifitm proteins restrict viral membrane hemifusion[J]. PLoS Pathog,2013,9(1):e1003124.
[20]	Poddar S, Hyde J L, Gorman M J, et al. The interferon-stimulated gene ifitm3 restricts infection and pathogenesis of arthritogenic and encephalitic alphaviruses[J]. J Virol,2016,90(19):8780.
[21]	Gorman M J, Poddar S, Farzan M, et al. The interferon-stimulated gene ifitm3 restricts west nile virus infection and pathogenesis[J]. J Virol,2011,90(18):8212.
[22]	Wrensch F, Hoffmann M, Gärtner S, et al. Virion background and efficiency of virion incorporation determine susceptibility of simian immunodeficiency virus env-driven viral entry to inhibition by ifitm proteins[J]. J Virol,2016,91(2):JVI.01488-16.
[23]	Diamond M S and Farzan M. The broad-spectrum antiviral functions of ifit and ifitm proteins[J]. Nat Rev Immunol,2013,13(1):46-57.
[24]	Li K, Markosyan R M, Zheng Y M, et al. Ifitm proteins restrict viral membrane hemifusion[J]. PLoS Pathog,2013,9(1):e1003124.
[25]	Aminibavilolyaee S, Choi Y J, Lee J H, et al. The antiviral effector ifitm3 disrupts intracellular cholesterol homeostasis to block viral entry[J]. Cell Host Microbe,2013,13(4):452-464.
[26]	Desai TM, Marin M, Chin CR, et al. Ifitm3 restricts influenza a virus entry by blocking the formation of fusion pores following virus-endosome hemifusion[J]. PLoS Pathog,2014,10(4):e1004048.

Please choose a citation manager

Content to export